Characteristic,Revenue in billion U.S. dollars
Roche (Switzerland)*,37.1
Amgen (U.S.),15.6
Novo Nordisk (Denmark)*,12.4
Gilead Sciences (U.S.),8.4
Merck Serono (Germany)*,8.2
Biogen Idec (U.S.),5.0
Celgene (U.S.),4.8
